[P48] Poster Session 48　Head and Neck Cancer（ICI）

[P48-1] Efficacy and safety analysis of nivolumab at a dose of 3mg/kg vs 240mg/body in head and neck squamous cell carcinoma

^○Takuma Kishida¹, Takuro Okada², Kiyoaki Tukahara², Isaku Okamoto², Hiroki Sato², Kunihiko Tokashiki², Yusuke Aihara², Tatsuya Ito², Gai Yamashita², Takahito Kondo¹, Kouki Miura³, Yuichiro Tada³, Tatsuo Masubuchi³, Chihiro Fushimi³, Yukiomi Kushihashi³, Kenji Hanyu³, Taku Yamashita⁴, Takashi Matsuki⁴, Kaho Momiyama⁴, Yuuki Harada⁴ (1.Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hachioji Medical Center, 2.Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, 3.Head and Neck Oncology Center, University of Health and Welfare Mita Hospital, 4.Department of Otorhinolaryngology, Head and Neck Surgery, Kitasato University Hospital)